Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

swissinfo.ch - swissinfo.ch - Study on US policies warns of billions in losses for Swiss pharma industry
Study on US policies warns of billions in losses for Swiss pharma industry
www.swissinfo.ch

An analysisExternal link commissioned by the pharmaceutical industry association Interpharma has examined the potential impact of US pharmaceutical policy on Switzerland. The study by the research institute BAK Economics highlights various possible…

forbes.com - Anna Forsythe - Why Pharma Needs To Rethink The Systematic Literature Review
Why Pharma Needs To Rethink The Systematic Literature Review
Forbes

​Anna Forsythe, pharmacist & health economist, is Founder & President of Oncoscope-AI, a real-time oncology evidence platform. I have worked with pharmaceutical evidence for more than 25 years, and I don't think I have ever seen it move as…

channelnewsasia.com - Huawei plans for more AI pharma tie-ups, says healthcare president
Huawei plans for more AI pharma tie-ups, says healthcare president
CNA

SHANGHAI, Aug 27: Chinese technology conglomerate Huawei plans to expand its AI cooperation with local pharmaceutical firms into drug development and clinical practice, a senior executive said. The move highlights Huawei's ambitions to gain a…

marketbeat.com - Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Still a Buy?
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Still a Buy?
MarketBeat

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) gapped up before the market opened on Thursday. The stock had previously closed at $16.90, but opened at $18.42. Ascentage Pharma Group International shares last…

globenewswire.com - hVIVO plc - hVIVO acquires CRS Berlin, expanding expertise into dermatology and women's health markets
hVIVO acquires CRS Berlin, expanding expertise into dermatology and women's health markets
GlobeNewswire

London, UK – 27 August 2026, hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, announces the acquisition of CRS Clinical Research Services Berlin…

marketbeat.com - Boone Capital Management LLC Invests $25.30 Million in BridgeBio Pharma, Inc. $BBIO
Boone Capital Management LLC Invests $25.30 Million in BridgeBio Pharma, Inc. $BBIO
MarketBeat

Boone Capital Management LLC purchased a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional…

marketbeat.com - Primecap Management Co. CA Buys New Stake in BridgeBio Pharma, Inc. $BBIO
Primecap Management Co. CA Buys New Stake in BridgeBio Pharma, Inc. $BBIO
MarketBeat

Primecap Management Co. CA purchased a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased…

marketbeat.com - Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Given Average Recommendation of 'Buy' by Brokerages
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Given Average Recommendation of 'Buy' by Brokerages
MarketBeat

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) has been assigned an average recommendation of 'Buy' from the ten brokerages that are currently covering the stock, MarketBeat.com reports. Eight research…

indianexpress.com - Sandeep Singh - In ten months, Japan invested Rs 1 lakh cr out of Rs 7 lakh cr targeted for 10 yrs: Goyal
In ten months, Japan invested Rs 1 lakh cr out of Rs 7 lakh cr targeted for 10 yrs: Goyal
The Indian Express

3 min read New Delhi, Tokyo Make us preferred source on Google Union Commerce Minister Piyush Goyal on Wednesday said that Japan is one of India's most strategic partners and India is working to expand the scope, scale and extent of the engagement.

globenewswire.com - Orion Oyj - Orion Corporation to commence acquisition of own shares for its share-based incentive plans
Orion Corporation to commence acquisition of own shares for its share-based incentive plans
GlobeNewswire

STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE Orion Corporation to commence acquisition of own shares for its share-based incentive plans On 27 August 2026, the Board of Directors of Orion…

seekingalpha.com - High Alpha Professor - Diodes: Its Three-Year Targets Are Already Showing Up In Q3 Guidance (NASDAQ:DIOD)
Diodes: Its Three-Year Targets Are Already Showing Up In Q3 Guidance (NASDAQ:DIOD)
Seeking Alpha

Diodes Incorporated is achieving its three-year financial targets far ahead of schedule, driven by AI-related demand and improved factory utilization. Q3 guidance projects $510M revenue, 35% gross margin, and $1.05 EPS, with AI server and…

yahoo.com - Maham Fatima - A Rejected Vote Pushes Capricor (CAPR) Toward A Narrower Path
A Rejected Vote Pushes Capricor (CAPR) Toward A Narrower Path
Yahoo!

On August 13, Capricor Therapeutics (NASDAQ: CAPR) held its second-quarter earnings call, just over two weeks after an FDA advisory committee voted 3 to 9 against the company's bid to treat cardiomyopathy in Duchenne muscular dystrophy patients on…

indianexpress.com - Express News Service - From UP, Rajasthan to Gujarat: Police bust interstate racket in popular BP drug Nicardia Retard
From UP, Rajasthan to Gujarat: Police bust interstate racket in popular BP drug Nicardia Retard
The Indian Express

4 min read Ahmedabad Make us preferred source on Google Gujarat Police have busted a sprawling multistate racket to manufacture and sell fake hypertension medication, swooping on counterfeit stocks of a popular drug at stores in Kheda and Kutch…

seekingalpha.com - SA Transcript Insights Editor - Agilent forecasts FY2026 revenue of $7.49B-$7.51B and EPS of $6.18-$6.21 as China returns to 9% growth (NYSE:A)
Agilent forecasts FY2026 revenue of $7.49B-$7.51B and EPS of $6.18-$6.21 as China returns to 9% growth (NYSE:A)
Seeking Alpha

Earnings Call Insights: Agilent Technologies (A) Q3 2026 'We delivered an excellent third quarter with strong performance on both the top and bottom lines.' (CEO, President & Director Padraig McDonnell) 'For the third quarter, Agilent reported…

mainebiz.biz - Renee Cordes - Roux Institute residency lineup spans fishing gear to cancer screening
Roux Institute residency lineup spans fishing gear to cancer screening
Mainebiz

From biodegradable fishing lures to cervical cancer screening solutions, 10 startups at the forefront of innovation have been selected for the next cohort of the Founder Residency program at Northeastern University's Roux Institute in Portland. The…

Receive a Daily briefing on Pharma Industry News

Get Started